Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Roche discloses novel tachykinin NK3 receptor antagonists

Jan. 21, 2009

New serotonin reuptake inhibitors and 5-HT1A receptor antagonists discovered at Wyeth

Jan. 21, 2009

ReNeuron receives U.K. approval for ground-breaking clinical trial of ReN-001 in ischemic stroke

Jan. 20, 2009

Alzheimer's Drug Discovery Foundation provides grant to Edunn Biotechnology

Jan. 20, 2009

AstraZeneca imparts novel metabotropic glutamate receptor oxadiazole ligands

Jan. 20, 2009

Peptimmune grants Novartis exclusive option to license PI-2301 for MS

Jan. 19, 2009

Scientists at Janssen describe new analgesic FAAH inhibitors in recent patent

Jan. 19, 2009

Novel mgluR5 positive allosteric modulators developed at GSK for schizophrenia

Jan. 19, 2009

Analgesic calcium channel alpha2-delta subreceptor ligands claimed by Kyowa Hakko Kirin

Jan. 19, 2009

Copernicus and the University of Kentucky to collaborate on DNA therapy for PD

Jan. 19, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...